| Q40346083 | A mouse model for the human pathogen Salmonella typhi |
| Q39296582 | A novel mouse model for Sézary syndrome using xenotransplantation of Sézary cells into immunodeficient RAG2(-/-) γc(-/-) mice |
| Q36210368 | Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand |
| Q56875356 | Alloreactivity but Failure to Reject Human Islet Transplants by Humanized Balb/c/Rag2−/−gc−/−Mice |
| Q64084883 | An Animal Model of Acute and Chronic Chagas Disease With the Reticulotropic Y Strain of That Depicts the Multifunctionality and Dysfunctionality of T Cells |
| Q48154259 | Analysis of the skin of mice humanized for the immune system |
| Q38043556 | Animal models in virus research: their utility and limitations |
| Q45303550 | Autonomous and extrinsic regulation of thymopoiesis in human immune system (HIS) mice |
| Q45888148 | Autoregulatory lentiviral vectors allow multiple cycles of doxycycline-inducible gene expression in human hematopoietic cells in vivo |
| Q34142453 | Bone marrow transplantation concurrently reconstitutes donor liver and immune system across host species barrier in mice |
| Q36781916 | CD4+ cell-dependent granuloma formation in humanized mice infected with mycobacteria. |
| Q64100649 | Cellular HIV Reservoirs and Viral Rebound from the Lymphoid Compartments of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine (EFdA)-Suppressed Humanized Mice |
| Q83133198 | Characterization of human B cells in umbilical cord blood-transplanted NOD/SCID mice |
| Q42591807 | Comparative study of human hematopoietic cell engraftment into BALB/c and C57BL/6 strain of rag-2/jak3 double-deficient mice |
| Q27022477 | Concise review: humanized models of tumor immunology in the 21st century: convergence of cancer research and tissue engineering |
| Q30664978 | Conserved and divergent aspects of human T-cell development and migration in humanized mice |
| Q33577361 | Current advances in humanized mouse models |
| Q51053068 | Delayed onset of graft-versus-host disease in immunodeficient human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cells. |
| Q44703734 | Determining the role of specific signaling molecules during lymphocyte development in vivo: instant transgenesis |
| Q47100953 | Development of Novel ImmunoPET Tracers to Image Human PD-1 Checkpoint Expression on Tumor-Infiltrating Lymphocytes in a Humanized Mouse Model |
| Q33520247 | Development of functional human NK cells in an immunodeficient mouse model with the ability to provide protection against tumor challenge |
| Q34707225 | Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice |
| Q36016352 | Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/SCID/IL2rγKO mice |
| Q37201746 | Development of murine models to study Hepatitis C virus induced liver pathogenesis |
| Q36918645 | Developmental pathways that generate natural-killer-cell diversity in mice and humans |
| Q35127565 | Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice |
| Q39432795 | Dynamics of memory and naïve CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rgammanull mice infected with CCR5-tropic HIV-1. |
| Q51960368 | Early development of human hematopoietic and acquired immune systems in new born NOD/Scid/Jak3null mice intrahepatic engrafted with cord blood-derived CD34 + cells. |
| Q34374708 | Effective elicitation of human effector CD8+ T Cells in HLA-B*51:01 transgenic humanized mice after infection with HIV-1. |
| Q33844310 | Engineering humanized mice for improved hematopoietic reconstitution |
| Q34066833 | Engineering the human thymic microenvironment to support thymopoiesis in vivo |
| Q45879357 | Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model |
| Q64947234 | Evaluation of the biocompatibility and stability of allogeneic tissue-engineered cartilage in humanized mice. |
| Q34542521 | Expansion of activated memory CD4+ T cells affects infectivity of CCR5-tropic HIV-1 in humanized NOD/SCID/JAK3null mice |
| Q36828943 | Experimental models of epidermolysis bullosa acquisita. |
| Q40089850 | Experimental study of tuberculosis: From animal models to complex cell systems and organoids. |
| Q33911359 | Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells |
| Q33721886 | Failure of effector function of human CD8+ T Cells in NOD/SCID/JAK3⁻/⁻ immunodeficient mice transplanted with human CD34+ hematopoietic stem cells |
| Q35164726 | Functional CD47/signal regulatory protein alpha (SIRP(alpha)) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo |
| Q33931029 | GM-CSF and IL-4 stimulate antibody responses in humanized mice by promoting T, B, and dendritic cell maturation |
| Q37608438 | Generation of Immunodeficient Mice Bearing Human Immune Systems by the Engraftment of Hematopoietic Stem Cells |
| Q28749033 | Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" mice |
| Q34156527 | Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model |
| Q39024287 | HTLV-1 Infection and Neuropathogenesis in the Context of Rag1-/-γc-/- (RAG1-Hu) and BLT Mice. |
| Q34016240 | HTLV-1 propels thymic human T cell development in "human immune system" Rag2⁻/⁻ gamma c⁻/⁻ mice |
| Q34100221 | Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- mice |
| Q34573221 | Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung |
| Q33577374 | Human allograft rejection in humanized mice: a historical perspective |
| Q42275227 | Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells |
| Q33995307 | Human hemato-lymphoid system mice: current use and future potential for medicine |
| Q42254467 | Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells |
| Q82262627 | Human immune system mice: current potential and limitations for translational research on human antibody responses |
| Q35784905 | Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice. |
| Q37299847 | Human intrathymic development: a selective approach. |
| Q35007600 | Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation. |
| Q34572945 | Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo |
| Q37555592 | Humanized mice for modeling human infectious disease: challenges, progress, and outlook. |
| Q34607151 | Humanized mice in translational biomedical research |
| Q26996648 | Humanized mice: novel model for studying mechanisms of human immune-based therapies |
| Q46145863 | Humanized mouse model for assessing the human immune response to xenogeneic and allogeneic decellularized biomaterials. |
| Q43098421 | Humanizing the mouse: in defense of murine models of critical illness |
| Q34794353 | IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo |
| Q37769917 | In vitro evolution and analysis of HIV-1 LTR-specific recombinases |
| Q36651190 | Increasing hematopoietic stem cell yield to develop mice with human immune systems |
| Q38734461 | Influence of Genetic Background on Hematologic and Histopathologic Alterations during Acute Granulocytic Anaplasmosis in 129/SvEv and C57BL/6J Mice Lacking Type I and Type II Interferon Signaling |
| Q33409934 | Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice |
| Q54976475 | Introduction of Human Flt3-L and GM-CSF into Humanized Mice Enhances the Reconstitution and Maturation of Myeloid Dendritic Cells and the Development of Foxp3+CD4+ T Cells. |
| Q34733983 | Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition |
| Q35921136 | Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis |
| Q42275677 | Modulation of antitumour immune responses by intratumoural Stat1 expression |
| Q40144992 | Molecular and immunological tools for the evaluation of the cellular immune response in the neotropical monkey Saimiri sciureus, a non-human primate model for malaria research |
| Q57201683 | Mouse Models for Human Hemato-Lymphopoiesis |
| Q38571256 | Mouse Models of Acute Respiratory Distress Syndrome: A Review of Analytical Approaches, Pathologic Features, and Common Measurements |
| Q34590684 | Mouse models with human immunity and their application in biomedical research |
| Q24673595 | Murine models to evaluate novel and conventional therapeutic strategies for cancer |
| Q36901928 | Nanoparticle characterization: state of the art, challenges, and emerging technologies. |
| Q53454854 | Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. |
| Q40328875 | Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease |
| Q30420391 | Pandemism of swine flu and its prospective drug therapy |
| Q33716675 | Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. |
| Q37419313 | Progress in the therapeutic applications of siRNAs against HIV-1. |
| Q91106720 | RELT negatively regulates the early phase of the T-cell response in mice |
| Q37566034 | RNA-interference-based gene therapy approaches to HIV type-1 treatment: tackling the hurdles from bench to bedside |
| Q26797326 | Regulatory T-Cell Development in the Human Thymus |
| Q37600607 | Renaissance for mouse models of human hematopoiesis and immunobiology |
| Q38155342 | Studying immunity to zoonotic diseases in the natural host - keeping it real |
| Q37346027 | The utilization of humanized mouse models for the study of human retroviral infections |
| Q37606516 | Toward a durable anti-HIV gene therapy based on RNA interference |
| Q35783479 | Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection |
| Q37354186 | Use of humanized severe combined immunodeficient mice for human vaccine development |
| Q21089599 | Vaccines: from empirical development to rational design |
| Q36201405 | What we are learning on HTLV-1 pathogenesis from animal models |
| Q57814647 | Workshop report: Experimental animal models for universal influenza vaccines |